GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
124 hedge funds and large institutions have $968M invested in Genomic Health, Inc. in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 43 increasing their positions, 47 reducing their positions, and 16 closing their positions.
Holders
124
Holders Change
-9
Holders Change %
-6.77%
% of All Funds
3.09%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
14
Increased
43
Reduced
47
Closed
16
Calls
$375K
Puts
–
Net Calls
+$375K
Net Calls Change
+$374K
Top Buyers
| 1 |
1
BlackRock
New York
|
$75.2M |
| 2 |
CWAM
2
Columbia Wanger Asset Management
Chicago,
Illinois
|
$50.6M |
| 3 |
3
Renaissance Technologies
New York
|
$23.1M |
| 4 |
AL
4
AJO LP
Philadelphia,
Pennsylvania
|
$4.74M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$49.3M |
